Healthcare provider profile · identity verified

Afi Y Bruce, MD

Internal Medicine · LAS VEGAS, NV · NPI 1467410639

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	608	218
Amlodipine Besylate	Amlodipine Besylate	561	198
Levothyroxine Sodium	Levothyroxine Sodium	450	153
Lisinopril	Lisinopril	401	146
Omeprazole	Omeprazole	283	106
Gabapentin	Gabapentin	248	100
Metformin Hcl	Metformin Hcl	220	82
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	215	49
Temazepam	Temazepam	202	25
Losartan Potassium	Losartan Potassium	179	68
Simvastatin	Simvastatin	171	56
Alendronate Sodium	Alendronate Sodium	164	66
Pantoprazole Sodium	Pantoprazole Sodium	157	57
Rosuvastatin Calcium	Rosuvastatin Calcium	157	58
Metoprolol Tartrate	Metoprolol Tartrate	153	59
Montelukast Sodium	Montelukast Sodium	142	48
Albuterol Sulfate Hfa	Albuterol Sulfate	132	51
Alprazolam	Alprazolam	130	27
Carvedilol	Carvedilol	130	47
Tramadol Hcl	Tramadol Hcl	130	30
Fluticasone Propionate	Fluticasone Propionate	127	59
Escitalopram Oxalate	Escitalopram Oxalate	126	45
Hydralazine Hcl	Hydralazine Hcl	126	42
Eliquis	Apixaban	113	35
Zolpidem Tartrate	Zolpidem Tartrate	112	16
Lovastatin	Lovastatin	106	41
Metoprolol Succinate	Metoprolol Succinate	102	44
Trazodone Hcl	Trazodone Hcl	97	22
Furosemide	Furosemide	86	42
Acetaminophen-Codeine	Acetaminophen With Codeine	83	19
Fenofibrate	Fenofibrate	83	29
Tamsulosin Hcl	Tamsulosin Hcl	83	31
Hydrochlorothiazide	Hydrochlorothiazide	80	31
Jardiance	Empagliflozin	79	22
Ibuprofen	Ibuprofen	76	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	24
Sertraline Hcl	Sertraline Hcl	73	27
Oxybutynin Chloride	Oxybutynin Chloride	67	22
Meloxicam	Meloxicam	66	26
Donepezil Hcl	Donepezil Hcl	61	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	20
Famotidine	Famotidine	56	21
Glimepiride	Glimepiride	55	16
Buspirone Hcl	Buspirone Hcl	52	17
Diazepam	Diazepam	51	12
Meclizine Hcl	Meclizine Hcl	50	29
Clonazepam	Clonazepam	49	suppressed
Lorazepam	Lorazepam	49	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	12
Clopidogrel	Clopidogrel Bisulfate	48	19
Valsartan	Valsartan	46	22
Diclofenac Sodium	Diclofenac Sodium	45	14
Pregabalin	Pregabalin	45	15
Fluoxetine Hcl	Fluoxetine Hcl	44	15
Allopurinol	Allopurinol	42	14
Acyclovir	Acyclovir	41	12
Atenolol	Atenolol	41	15
Baclofen	Baclofen	41	15
Glipizide	Glipizide	41	18
Hydroxyzine Hcl	Hydroxyzine Hcl	39	11
Potassium Chloride	Potassium Chloride	39	19
Tizanidine Hcl	Tizanidine Hcl	39	21
Memantine Hcl	Memantine Hcl	38	14
Trulicity	Dulaglutide	38	suppressed
Azithromycin	Azithromycin	36	32
Nystatin	Nystatin	36	23
Ramipril	Ramipril	36	13
Mounjaro	Tirzepatide	35	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	11
Finasteride	Finasteride	34	11
Pravastatin Sodium	Pravastatin Sodium	34	12
Warfarin Sodium	Warfarin Sodium	34	11
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	15
Primidone	Primidone	32	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	12
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	suppressed
Metformin Hcl Er	Metformin Hcl	28	12
Ozempic	Semaglutide	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Ciclopirox	Ciclopirox	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Estradiol	Estradiol	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Naproxen	Naproxen	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Prednisone	Prednisone	24	19
Irbesartan	Irbesartan	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Terazosin Hcl	Terazosin Hcl	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	21	20
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Clonidine Hcl	Clonidine Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Carisoprodol	Carisoprodol	19	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cephalexin	Cephalexin	16	11
Fluconazole	Fluconazole	16	15
Glipizide-Metformin	Glipizide/Metformin Hcl	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Topiramate	Topiramate	16	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Linzess	Linaclotide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Synthroid	Levothyroxine Sodium	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Belsomra	Suvorexant	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	12	suppressed
Digoxin	Digoxin	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error